On April 7, Jiangsu Hengrui Pharmaceuticals (01276) spent 3.6215 million yuan to repurchase 64,800 A shares.
Hengrui Medicine (01276) announced that it will spend 3.6215 million yuan to repurchase 64,800 A-shares on April 7, 2026.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on April 7, 2026, it spent 3.6215 million yuan to repurchase 64,800 A-shares.
Related Articles
Zhejiang Express (00576): Zheshang appoints Lv Xiaoping as the company's compliance director.
GOLDSTREAM INV (01328) intends to invest no more than 8 million US dollars in the cornerstone investment of Qunhe Technology's IPO.
Shandong Sinocera Functional Material (300285.SZ): A fire accident occurred in Factory 1 of the East Zone of the company's Second Plant.
Zhejiang Express (00576): Zheshang appoints Lv Xiaoping as the company's compliance director.
GOLDSTREAM INV (01328) intends to invest no more than 8 million US dollars in the cornerstone investment of Qunhe Technology's IPO.
Shandong Sinocera Functional Material (300285.SZ): A fire accident occurred in Factory 1 of the East Zone of the company's Second Plant.
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026
